Kazia Therapeutics ( (KZIA) ) has provided an announcement.

Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, ...

Starting from applications submitted on January 1st of the following year, the new drug approval fee will be 410 million won. The Ministry of Food and Drug Safety noted, "The process from new drug ...

In an exercise that is required every five years, Luzerne County is reassessing natural and man-made threats to residents and possible ways to reduce the risks.

In 1976, the Eagles released the song, “Life in the Fast Lane,” as part of their iconic album, Hotel California. Approximately 16 years later, ...

Rule could make more medications available over the counter through a process called Additional Condition of Non-prescription Use (ACNU).

NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's potential impact on NGENF's stock value.

The US Food and Drug Administration (FDA) has announced a final rule expanding the approval pathway for nonprescription drug ...

Process development strategies provide multiple benefits across all stages of the drug design and development process, from initial discovery to regulatory approval ... a result, new drugs are ...

Aquestive Therapeutics' Anaphylm is nearing FDA approval, potentially disrupting the U.S. anaphylaxis market dominated by ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the U.S. Food and Drug Administration (FDA) has ...

Investment themes to consider for 2025 include the AI revolution, data centers, power, biotech, regional banks, defense ...